A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells

References

• Kunz-Schughart LA, Freyer JP, Hofstaedter F, et al. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004;9:273–285.
   PubMed Web of Science ®Google Scholar
• Cukierman E, Pankov R, Stevens DR, et al. Taking cell-matrix adhesions to the third dimension. Science 2001;294:1708–1712.
   PubMed Web of Science ®Google Scholar
• Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998;8:437–441.
   PubMed Web of Science ®Google Scholar
• Delmer A, Marie JP, Thevenin D, et al. Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity. Leuk Lymphoma 1993;10:67–71.
   PubMed Web of Science ®Google Scholar
• Khoury HJ, Garcia-Manero G, Borthakur G, et al. A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias. Cancer 2012;118: 3556–3564.
   PubMed Web of Science ®Google Scholar
• Wacheck V, Lahn M, Dickinson G, et al. Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics. Cancer Manag Res 2011;3:157–175.
   PubMedGoogle Scholar
• Lapusan S, Vidriales MB, Thomas X, et al. Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia. Invest New Drugs 2012;30:1121–1131.
   PubMed Web of Science ®Google Scholar
• Colmone A, Amorim M, Pontier AL, et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008;322:1861–1865.
   PubMed Web of Science ®Google Scholar
• Li ZW, Dalton WS. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006;20:333–342.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Kuo ML. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy. Pediatr Hematol Oncol 2011;28:640–646.
   PubMed Web of Science ®Google Scholar
• Sipkins DA, Wei X, Wu JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005;435:969–973.
   PubMed Web of Science ®Google Scholar
• Oran B, Wagner JE, DeFor TE, et al. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2011;17: 1327–1334.
   PubMed Web of Science ®Google Scholar
• Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 2009; 23:43–52.
   PubMed Web of Science ®Google Scholar
• McQueen T, Konopleva M, Andreeff M. Activity of targeted molecular therapeutics against primary AML cells: putative role of the bone marrow microenvironment. Blood 2005;106(Suppl. 1): Abstract 2304.
   PubMed Web of Science ®Google Scholar
• Kojima K, McQueen T, Chen Y, et al. p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1{alpha}-mediated down-regulation of CXCL12. Blood 2011;118:4431–4439.
   PubMed Web of Science ®Google Scholar
• Fischbach C, Chen R, Matsumoto T, et al. Engineering tumors with 3D scaffolds. Nat Methods 2007;4:855–860.
   PubMed Web of Science ®Google Scholar
• Dainiak MB, Savina IN, Musolino I, et al. Biomimetic macroporous hydrogel scaffolds in a high-throughput screening format for cell-based assays. Biotechnol Prog 2008;24:1373–1383.
   PubMed Web of Science ®Google Scholar
• Blanco TM, Mantalaris A, Bismarck A, et al. The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. Biomaterials 2010;31:2243–2251.
   PubMed Web of Science ®Google Scholar
• Colado E, Alvarez-Fernandez S, Maiso P, et al. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34 + immature phenotype. Haematologica 2008;93:57–66.
   PubMed Web of Science ®Google Scholar
• Nirmalanandhan VS, Duren A, Hendricks P, et al. Activity of anticancer agents in a three-dimensional cell culture model. Assay Drug Dev Technol 2010;8:581–590.
   PubMed Web of Science ®Google Scholar
• Drexler HG, Quentmeier H, MacLeod RA, et al. Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk Res 1995;19:681–691.
   PubMed Web of Science ®Google Scholar
• Asou H, Tashiro S, Hamamoto K, et al. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991;77:2031–2036.
   PubMed Web of Science ®Google Scholar
• Zheng R, Bailey E, Nguyen B, et al. Further activation of FLT3 mutants by FLT3 ligand. Oncogene 2011;30:4004–4014.
   PubMed Web of Science ®Google Scholar
• Burke PJ, Diggs CH, Owens AH Jr.Factors in human serum affecting the proliferation of normal and leukemic cells. Cancer Res 1973;33:800–806.
   PubMed Web of Science ®Google Scholar
• Karp JE, Burke PJ. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells. Cancer Res 1976;36: 1674–1679.
   PubMed Web of Science ®Google Scholar
• Hozumi M. Established leukemia cell lines: their role in the understanding and control of leukemia proliferation. Crit Rev Oncol Hematol 1985;3:235–277.
   PubMed Web of Science ®Google Scholar
• Zhi L, Wang M, Rao Q, et al. Enrichment of N-cadherin and Tie2-bearing CD34+/CD38-/CD123 + leukemic stem cells by chemotherapy-resistance. Cancer Lett 2010;296:65–73.
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425: 836–841.
   PubMed Web of Science ®Google Scholar
• Haug JS, He XC, Grindley JC, et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008;2:367–379.
   PubMed Web of Science ®Google Scholar
• Hosokawa K, Arai F, Yoshihara H, et al. Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow. Cell Stem Cell 2010;6:194–198.
   Google Scholar
• Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131:324–336.
   PubMed Web of Science ®Google Scholar
• Vaiselbuh SR, Edelman M, Lipton JM, et al. Ectopic human mesenchymal stem cell-coated scaffolds in NOD/SCID mice: an in vivo model of the leukemia niche. Tissue Eng Part C Methods 2010;16: 1523–1531.
   PubMed Web of Science ®Google Scholar